vs
Idexx Laboratories（IDXX）与Primo Brands Corp（PRMB）财务数据对比。点击上方公司名可切换其他公司
Primo Brands Corp的季度营收约是Idexx Laboratories的1.4倍（$1.6B vs $1.1B），Idexx Laboratories净利率更高（22.8% vs -0.8%，领先23.6%），Idexx Laboratories自由现金流更多（$326.3M vs $57.3M）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
Primo Brands Corp是一家美加合资饮用水企业，主营多规格桶装水、饮水机、自助补水设备及净水家电，总部位于美国佛罗里达州坦帕市，服务覆盖美国、加拿大、欧洲及以色列的住宅与商业客户。
IDXX vs PRMB — 直观对比
营收规模更大
PRMB
是对方的1.4倍
$1.1B
净利率更高
IDXX
高出23.6%
-0.8%
自由现金流更多
IDXX
多$269.0M
$57.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.6B |
| 净利润 | $248.2M | $-13.0M |
| 毛利率 | 60.3% | 27.7% |
| 营业利润率 | 28.9% | 1.2% |
| 净利率 | 22.8% | -0.8% |
| 营收同比 | 14.3% | — |
| 净利润同比 | 14.8% | — |
| 每股收益（稀释后） | $3.09 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXPRMB
| Q4 25 | $1.1B | $1.6B | ||
| Q3 25 | $1.1B | $1.8B | ||
| Q2 25 | $1.1B | $1.7B | ||
| Q1 25 | $998.4M | $1.6B | ||
| Q4 24 | $954.3M | — | ||
| Q3 24 | $975.5M | $0 | ||
| Q2 24 | $1.0B | $1.3B | ||
| Q1 24 | $964.1M | $1.1B |
净利润IDXXPRMB
| Q4 25 | $248.2M | $-13.0M | ||
| Q3 25 | $274.6M | $16.8M | ||
| Q2 25 | $294.0M | $27.6M | ||
| Q1 25 | $242.7M | $28.7M | ||
| Q4 24 | $216.1M | — | ||
| Q3 24 | $232.8M | $-2.0K | ||
| Q2 24 | $203.3M | $54.5M | ||
| Q1 24 | $235.6M | $33.5M |
毛利率IDXXPRMB
| Q4 25 | 60.3% | 27.7% | ||
| Q3 25 | 61.8% | 29.9% | ||
| Q2 25 | 62.6% | 31.3% | ||
| Q1 25 | 62.4% | 32.3% | ||
| Q4 24 | 59.8% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 61.7% | 32.7% | ||
| Q1 24 | 61.5% | 30.4% |
营业利润率IDXXPRMB
| Q4 25 | 28.9% | 1.2% | ||
| Q3 25 | 32.1% | 8.3% | ||
| Q2 25 | 33.6% | 6.5% | ||
| Q1 25 | 31.7% | 9.5% | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 31.2% | — | ||
| Q2 24 | 26.3% | 12.1% | ||
| Q1 24 | 31.0% | 11.0% |
净利率IDXXPRMB
| Q4 25 | 22.8% | -0.8% | ||
| Q3 25 | 24.8% | 1.0% | ||
| Q2 25 | 26.5% | 1.6% | ||
| Q1 25 | 24.3% | 1.8% | ||
| Q4 24 | 22.7% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 20.3% | 4.1% | ||
| Q1 24 | 24.4% | 2.9% |
每股收益（稀释后）IDXXPRMB
| Q4 25 | $3.09 | $-0.03 | ||
| Q3 25 | $3.40 | $0.04 | ||
| Q2 25 | $3.63 | $0.07 | ||
| Q1 25 | $2.96 | $0.08 | ||
| Q4 24 | $2.62 | — | ||
| Q3 24 | $2.80 | $-20.00 | ||
| Q2 24 | $2.44 | $0.25 | ||
| Q1 24 | $2.81 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $376.7M |
| 总债务越低越好 | $450.0M | $5.2B |
| 股东权益账面价值 | $1.6B | $3.0B |
| 总资产 | $3.4B | $10.6B |
| 负债/权益比越低杠杆越低 | 0.28× | 1.72× |
8季度趋势，按日历期对齐
现金及短期投资IDXXPRMB
| Q4 25 | $180.1M | $376.7M | ||
| Q3 25 | $208.2M | — | ||
| Q2 25 | $164.6M | — | ||
| Q1 25 | $164.0M | — | ||
| Q4 24 | $288.3M | — | ||
| Q3 24 | $308.6M | — | ||
| Q2 24 | $401.6M | — | ||
| Q1 24 | $397.4M | — |
总债务IDXXPRMB
| Q4 25 | $450.0M | $5.2B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $5.1B | ||
| Q1 25 | — | $5.0B | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDXXPRMB
| Q4 25 | $1.6B | $3.0B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.5B | $3.2B | ||
| Q1 25 | $1.4B | $3.3B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $-2.0K | ||
| Q2 24 | $1.6B | $-296.8M | ||
| Q1 24 | $1.6B | $-349.8M |
总资产IDXXPRMB
| Q4 25 | $3.4B | $10.6B | ||
| Q3 25 | $3.4B | $11.0B | ||
| Q2 25 | $3.3B | $11.0B | ||
| Q1 25 | $3.2B | $11.0B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.4B | $0 | ||
| Q2 24 | $3.4B | — | ||
| Q1 24 | $3.4B | — |
负债/权益比IDXXPRMB
| Q4 25 | 0.28× | 1.72× | ||
| Q3 25 | — | 1.61× | ||
| Q2 25 | — | 1.57× | ||
| Q1 25 | — | 1.51× | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $203.1M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $57.3M |
| 自由现金流率自由现金流/营收 | 29.9% | 3.7% |
| 资本支出强度资本支出/营收 | 2.7% | 9.4% |
| 现金转化率经营现金流/净利润 | 1.43× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | $302.9M |
8季度趋势，按日历期对齐
经营现金流IDXXPRMB
| Q4 25 | $355.8M | $203.1M | ||
| Q3 25 | $402.3M | $283.4M | ||
| Q2 25 | $185.7M | $155.0M | ||
| Q1 25 | $238.0M | $38.8M | ||
| Q4 24 | $262.0M | — | ||
| Q3 24 | $220.1M | $0 | ||
| Q2 24 | $248.3M | $102.5M | ||
| Q1 24 | $198.6M | $6.0M |
自由现金流IDXXPRMB
| Q4 25 | $326.3M | $57.3M | ||
| Q3 25 | $371.2M | $167.7M | ||
| Q2 25 | $151.6M | $101.1M | ||
| Q1 25 | $207.9M | $-23.2M | ||
| Q4 24 | $232.8M | — | ||
| Q3 24 | $192.0M | — | ||
| Q2 24 | $215.0M | $61.4M | ||
| Q1 24 | $168.3M | $-17.5M |
自由现金流率IDXXPRMB
| Q4 25 | 29.9% | 3.7% | ||
| Q3 25 | 33.6% | 9.5% | ||
| Q2 25 | 13.7% | 5.8% | ||
| Q1 25 | 20.8% | -1.4% | ||
| Q4 24 | 24.4% | — | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 21.4% | 4.7% | ||
| Q1 24 | 17.5% | -1.5% |
资本支出强度IDXXPRMB
| Q4 25 | 2.7% | 9.4% | ||
| Q3 25 | 2.8% | 6.6% | ||
| Q2 25 | 3.1% | 3.1% | ||
| Q1 25 | 3.0% | 3.8% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.3% | 3.1% | ||
| Q1 24 | 3.1% | 2.1% |
现金转化率IDXXPRMB
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.47× | 16.87× | ||
| Q2 25 | 0.63× | 5.62× | ||
| Q1 25 | 0.98× | 1.35× | ||
| Q4 24 | 1.21× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.22× | 1.88× | ||
| Q1 24 | 0.84× | 0.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
PRMB
| Regional Spring Water | $765.1M | 49% |
| Purified Water | $484.5M | 31% |
| Other | $188.4M | 12% |
| Premium Water | $90.3M | 6% |
| Other Water | $25.8M | 2% |
